News Focus
News Focus
icon url

md1225

04/01/14 6:06 AM

#170827 RE: biopharm #170822

Great Post! Thank you biopharm, this is the number one post of the past two days folks!
icon url

swg_tdr

04/01/14 2:36 PM

#170915 RE: biopharm #170822

biopharm, terrific post, almost poetic

thanks,
N
icon url

biopharm

04/21/14 9:59 PM

#173727 RE: biopharm #170822

Hakan Mellstedt : Peregrine Pharmaceuticals KOL :

ok, not much free time this past week and I'll toss out a -nth degree of separation...

The following search ( restricted to 1 week only ) on KOL Hakan Mellstedt only brings up "research gate only.." results

Looking into those results very quickly.... it reveals that Hakan has a little influx of new "followers"

https://www.google.com/#q=hakan+mellstedt&tbs=qdr:w

I could probably narrow it down a bit more if we look at all the names involved and under "following" they only give you the last 10... so you will notice Hakan within these 10 and makes sense, because the search is done just for this past week so they added Hakan just this past week.

To just keep track of Hakan's numbers on research gate as of April 21, 2014

Following: 23

Followers: 64


almost 3 to 1... looks like others are more interested in what Hakan has been up to and hopefully--- its astronomical type of research.


About

Tumor immunology with a focus on immunotherapy using monoclonal antibodies and cancer vaccines. The present research is addressing structural and functional characterization of ROR1 in hematological malignancies and solid tumors and the developement of therapeutic strategies using small molecules targeting the TK domain of ROR1 as well as monoclonal antibodies recognizing the extracellular part of ROR1. A future strategy will also include developement of active ROR1 specific immunotherapy

http://www.researchgate.net/profile/Hakan_Mellstedt